These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21553150)

  • 1. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.
    Kim HJ; Bae JS; Chang IH; Kim KD; Lee J; Shin HD; Lee JY; Kim WJ; Kim W; Myung SC
    World J Urol; 2012 Apr; 30(2):225-32. PubMed ID: 21553150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
    Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
    Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.
    Zheng SL; Augustsson-Bälter K; Chang B; Hedelin M; Li L; Adami HO; Bensen J; Li G; Johnasson JE; Turner AR; Adams TS; Meyers DA; Isaacs WB; Xu J; Grönberg H
    Cancer Res; 2004 Apr; 64(8):2918-22. PubMed ID: 15087412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men.
    Song J; Kim DY; Kim CS; Kim HJ; Lee DH; Lee HM; Ko W; Lee G
    Cancer Genet Cytogenet; 2009 Apr; 190(2):88-92. PubMed ID: 19380025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pooled analysis of association between a genetic variant in the 3'-untranslated region of Toll-like receptor 4 and cancer risk.
    Wang X; Xu Z; Miao CH
    Genet Mol Res; 2015 Dec; 14(4):17847-55. PubMed ID: 26782430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
    Shui IM; Stark JR; Penney KL; Schumacher FR; Epstein MM; Pitt MJ; Stampfer MJ; Tamimi RM; Lindstrom S; Sesso HD; Fall K; Ma J; Kraft P; Giovannucci E; Mucci LA
    Prostate; 2012 Feb; 72(2):209-16. PubMed ID: 21563195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
    Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
    Lindström S; Hunter DJ; Grönberg H; Stattin P; Wiklund F; Xu J; Chanock SJ; Hayes R; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):873-6. PubMed ID: 20200442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.
    Choi SY; Kim HJ; Cheong HS; Myung SC
    Korean J Urol; 2015 Jan; 56(1):19-30. PubMed ID: 25598933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
    Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
    Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.
    Kim MS; Lee HN; Kim HJ; Myung SC
    Int Braz J Urol; 2015; 41(5):869-97. PubMed ID: 26689513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in the HEPSIN gene are associated with susceptibility to prostate cancer.
    Kim HJ; Han JH; Chang IH; Kim W; Myung SC
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):353-8. PubMed ID: 22665141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of TLR2 and TLR4 non-missense single nucleotide polymorphisms with type 2 diabetes risk in a southern Chinese population: a case-control study.
    Huang WH; Nie LH; Zhang LJ; Jing LP; Dong F; Wang M; Zhang N; Liu Y; Zhang BH; Chen C; Lin HS; Wei XC; Yang G; Jing CX
    Genet Mol Res; 2015 Jul; 14(3):8694-705. PubMed ID: 26345801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 genetic variation and advanced prostate cancer risk.
    Cheng I; Plummer SJ; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):352-5. PubMed ID: 17301271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
    Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
    Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One functional variant in the 3'-untranslated region of TLR4 is associated with the elevated risk of ventilator-associated pneumonia in the patients with chronic obstructive pulmonary disease.
    Zhao X; Feng J; Zhang L; Zhao F; Li M; Du Y; Li Y; Wu Q; Li G
    J Cell Physiol; 2019 Aug; 234(10):18879-18886. PubMed ID: 30972742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
    Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
    Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.